Vale Complete Copper Acquisition in Africa

Companhia Vale do Rio Doce (Vale) announces that it has successfully completed the previously announced transaction which creates a 50:50 joint venture between Vale and African Rainbow Minerals Limited (ARM) for the future development and operation of the assets of TEAL Exploration & Mining Incorporated (TEAL), enhancing Vale’s strategic growth options in the copper business in Africa.

The transaction involved a series of steps, through which Vale has acquired a 50% interest in TEAL’s subsidiaries for CAD$ 81 million, and TEAL has been taken private by ARM at a price of CAD$3.00 in cash per TEAL share. As a result of this transaction, TEAL’s assets will be directly or indirectly owned by a newly-created joint venture company owned by Vale and ARM (50:50).

TEAL's trading on the Johannesburg Stock Exchange (JSE) was suspended at the opening of trading today and its common shares will be delisted from the JSE on April 3, 2009. An application to delist TEAL’s common shares has been filed with the Toronto Stock Exchange (TSX) and the delisting is expected to be effective shortly. An application is expected to be filed shortly to allow TEAL to cease to be a reporting issuer under applicable Canadian securities laws.

We expect this new joint venture to add significant value to our shareholders over the medium to long term, since it enhances our global copper growth platform and contributes to the diversification of our asset portfolio, providing simultaneously geographic diversification into a region with the highest potential for mineral exploration in the world, the African copperbelt.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.